Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase II trial of AR1008 for treatment of obesity

Trial Profile

Phase II trial of AR1008 for treatment of obesity

Status: Planning
Phase of Trial: Phase II

Latest Information Update: 20 Oct 2016

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs AR 1008 (Primary)
  • Indications Obesity
  • Focus Therapeutic Use

Most Recent Events

  • 20 Oct 2016 New trial record
  • 01 Jun 2016 According to an AriBio media release, this trial will be conducted in 2017.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top